AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
IMPAIRED FITNESS OF FOSCARNET-RESISTANT STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: TACHEDJIAN G MELLORS JW BAZMI H MILLS J
Citation: G. Tachedjian et al., IMPAIRED FITNESS OF FOSCARNET-RESISTANT STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, AIDS research and human retroviruses, 14(12), 1998, pp. 1059-1064
IL-12 AND DENDRITIC CELLS LOADED WITH LIPOSOME PLUS HIV-1 PROTEINS STIMULATE ANTI-HIV-1 CYTOTOXIC T-LYMPHOCYTE REACTIVITY IN CD8(-CELLS FROM PATIENTS RECEIVING COMBINATION ANTIRETROVIRAL THERAPY() T)
Authors: RINALDO CR HUANG XL FAN Z MARGOLICK JB ALSHBOUL Q ZHENG L MCMAHON DK RIDDLER SA MELLORS JW
Citation: Cr. Rinaldo et al., IL-12 AND DENDRITIC CELLS LOADED WITH LIPOSOME PLUS HIV-1 PROTEINS STIMULATE ANTI-HIV-1 CYTOTOXIC T-LYMPHOCYTE REACTIVITY IN CD8(-CELLS FROM PATIENTS RECEIVING COMBINATION ANTIRETROVIRAL THERAPY() T), Journal of leukocyte biology, 1998, pp. 32-32
SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP
Authors: GULICK RM MELLORS JW HAVLIR D ERON JJ GONZALEZ C MCMAHON D JONAS L MEIBOHM A HOLDER D SCHLEIF WA CONDRA JH EMINI EA ISAACS R CHODAKEWITZ JA RICHMAN DD
Citation: Rm. Gulick et al., SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP, JAMA, the journal of the American Medical Association, 280(1), 1998, pp. 35-41
ANTIRETROVIRAL DRUG-RESISTANCE TESTING IN ADULTS WITH HIV-INFECTION -IMPLICATIONS FOR CLINICAL MANAGEMENT
Authors: HIRSCH MS CONWAY B DAQUILA RT JOHNSON VA BRUNVEZINET F CLOTET B DEMETER LM HAMMER SM JACOBSEN DM KURITZKES DR LOVEDAY C MELLORS JW VELLA S RICHMAN DD
Citation: Ms. Hirsch et al., ANTIRETROVIRAL DRUG-RESISTANCE TESTING IN ADULTS WITH HIV-INFECTION -IMPLICATIONS FOR CLINICAL MANAGEMENT, JAMA, the journal of the American Medical Association, 279(24), 1998, pp. 1984-1991
VIRAL-LOAD TESTS PROVIDE VALUABLE ANSWERS
Authors: MELLORS JW
Citation: Jw. Mellors, VIRAL-LOAD TESTS PROVIDE VALUABLE ANSWERS, Scientific American, 279(1), 1998, pp. 90-93
A NOVEL POLYMORPHISM AT CODON-333 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CAN FACILITATE DUAL RESISTANCE TO ZIDOVUDINEAND L-2',3'-DIDEOXY-3'-THIACYTIDINE
Authors: KEMP SD SHI CF BLOOR S HARRIGAN PR MELLORS JW LARDER BA
Citation: Sd. Kemp et al., A NOVEL POLYMORPHISM AT CODON-333 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CAN FACILITATE DUAL RESISTANCE TO ZIDOVUDINEAND L-2',3'-DIDEOXY-3'-THIACYTIDINE, Journal of virology, 72(6), 1998, pp. 5093-5098
GUIDELINES FOR THE USE OF ANTIRETROVIRAL AGENTS IN HIV-INFECTED ADULTS AND ADOLESCENTS
Authors: ANDERSON J ARMSTEAD R BAKER AC BARR D BOZZETTE S COX S DELANEY M GORDIN F GREAVES W HARRINGTON M HENNING JJ HIRSCH MS JACOBS J MARLINK R MAXWELL C MELLORS JW NASH DB PERRYMAN S SCHOOLEY RT SHERER R SPECTOR SA TORRES G VOLBERDING P BRADY BA COHEN O DANIELS EM FEIGAL D FEINBERG M GAYLE HD GRAYDON TR KAPLAN J MACHER A MARTIN RF MASUR H MOFENSON L MURRAY J ONEILL J PEREZ LC RISEBERG R SHEKAR S STANLEY SK WHITESCARVER J CARPENTER C BALLY G RACHLIS A STANLEY SK BRADY BA DANIELS EM
Citation: J. Anderson et al., GUIDELINES FOR THE USE OF ANTIRETROVIRAL AGENTS IN HIV-INFECTED ADULTS AND ADOLESCENTS, Annals of internal medicine, 128(12), 1998, pp. 1079-1100
HOT PAPERS - AIDS BIOLOGY - QUANTITATION OF HIV-1 RNA IN PLASMA PREDICTS OUTCOME AFTER SEROCONVERSION BY MELLORS,J.W., KINGSLEY,L.A., RINALDO,C.R., JR., TODD,J.A., HOO,B.S., KOKKA,R.P., GUPTA,P., PROGNOSIS IN HIV-1 INFECTION PREDICTED BY THE QUANTITY OF VIRUS IN PLASMA BY J.W. MELLORS, RINALDO,C.R., JR, GUPTA,P., WHITE,R.M., TODD,J.A., KINGSLEY,L.A. - COMMENTS
Authors: MELLORS JW
Citation: Jw. Mellors, HOT PAPERS - AIDS BIOLOGY - QUANTITATION OF HIV-1 RNA IN PLASMA PREDICTS OUTCOME AFTER SEROCONVERSION BY MELLORS,J.W., KINGSLEY,L.A., RINALDO,C.R., JR., TODD,J.A., HOO,B.S., KOKKA,R.P., GUPTA,P., PROGNOSIS IN HIV-1 INFECTION PREDICTED BY THE QUANTITY OF VIRUS IN PLASMA BY J.W. MELLORS, RINALDO,C.R., JR, GUPTA,P., WHITE,R.M., TODD,J.A., KINGSLEY,L.A. - COMMENTS, The Scientist, 11(15), 1997, pp. 12-12
HIV-1 VIRAL LOAD AND CLINICAL OUTCOME - REVIEW OF RECENT STUDIES
Authors: RIDDLER SA MELLORS JW
Citation: Sa. Riddler et Jw. Mellors, HIV-1 VIRAL LOAD AND CLINICAL OUTCOME - REVIEW OF RECENT STUDIES, AIDS, 11, 1997, pp. 141-148
A RECOMBINANT RETROVIRAL SYSTEM FOR RAPID IN-VIVO ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUSCEPTIBILITY TO REVERSE-TRANSCRIPTASE INHIBITORS
Authors: SHI CF MELLORS JW
Citation: Cf. Shi et Jw. Mellors, A RECOMBINANT RETROVIRAL SYSTEM FOR RAPID IN-VIVO ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUSCEPTIBILITY TO REVERSE-TRANSCRIPTASE INHIBITORS, Antimicrobial agents and chemotherapy, 41(12), 1997, pp. 2781-2785
PROGNOSIS IN HIV-1 INFECTION PREDICTED BY THE QUANTITY OF VIRUS IN PLASMA (VOL 272, PG 1167, 1996)
Authors: MELLORS JW
Citation: Jw. Mellors, PROGNOSIS IN HIV-1 INFECTION PREDICTED BY THE QUANTITY OF VIRUS IN PLASMA (VOL 272, PG 1167, 1996), Science, 275(5296), 1997, pp. 14-14
TREATMENT WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE IN ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND PRIOR ANTIRETROVIRAL THERAPY
Authors: GULICK RM MELLORS JW HAVLIR D ERON JJ GONZALEZ C MCMAHON D RICHMAN DD VALENTINE FT JONAS L MEIBOHM A EMINI EA CHODAKEWITZ JA
Citation: Rm. Gulick et al., TREATMENT WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE IN ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND PRIOR ANTIRETROVIRAL THERAPY, The New England journal of medicine, 337(11), 1997, pp. 734-739
CLINICAL EFFICACY OF MONOTHERAPY WITH STAVUDINE COMPARED WITH ZIDOVUDINE IN HIV-INFECTED, ZIDOVUDINE-EXPERIENCED PATIENTS - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL
Authors: SPRUANCE SL PAVIA AT MELLORS JW MURPHY R GATHE J STOOL E JEMSEK JG DELLAMONICA P CROSS A DUNKLE L
Citation: Sl. Spruance et al., CLINICAL EFFICACY OF MONOTHERAPY WITH STAVUDINE COMPARED WITH ZIDOVUDINE IN HIV-INFECTED, ZIDOVUDINE-EXPERIENCED PATIENTS - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL, Annals of internal medicine, 126(5), 1997, pp. 355
PLASMA VIRAL LOAD AND CD4(-1 INFECTION() LYMPHOCYTES AS PROGNOSTIC MARKERS OF HIV)
Authors: MELLORS JW MUNOZ A GIORGI JV MARGOLICK JB TASSONI CJ GUPTA P KINGSLEY LA TODD JA SAAH AJ DETELS R PHAIR JP RINALDO CR
Citation: Jw. Mellors et al., PLASMA VIRAL LOAD AND CD4(-1 INFECTION() LYMPHOCYTES AS PROGNOSTIC MARKERS OF HIV), Annals of internal medicine, 126(12), 1997, pp. 946-954
CLOSING IN ON HUMAN IMMUNODEFICIENCY VIRUS-1
Authors: MELLORS JW
Citation: Jw. Mellors, CLOSING IN ON HUMAN IMMUNODEFICIENCY VIRUS-1, Nature medicine, 2(3), 1996, pp. 274-275
SAFETY AND PHARMACOKINETICS OF 5-CHLORO-2',3'-DIDEOXY-3' FLUOROURIDINE (935U83) FOLLOWING ORAL-ADMINISTRATION OF ESCALATING SINGLE DOSES INHUMAN IMMUNODEFICIENCY VIRUS-INFECTED ADULTS
Authors: RIDDLER SA WANG LH BARTLETT JA SAVINA PM PACKARD MV MCMAHON DK BLUM MR DUNN JA ELKINS MM MELLORS JW
Citation: Sa. Riddler et al., SAFETY AND PHARMACOKINETICS OF 5-CHLORO-2',3'-DIDEOXY-3' FLUOROURIDINE (935U83) FOLLOWING ORAL-ADMINISTRATION OF ESCALATING SINGLE DOSES INHUMAN IMMUNODEFICIENCY VIRUS-INFECTED ADULTS, Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2842-2847
THE VIRAL ACTIVATION TRANSFUSION STUDY (VATS) - RATIONALE, OBJECTIVES, AND DESIGN OVERVIEW
Authors: BUSCH MP COLLIER A GERNSHEIMER T CARRINGTON JD FLANIGAN TP KASHKARI M KENNEDY M KUMAR PN LANE TA MELLORS JW MOHANDAS K POLLARD RB VIELE M YOMTOVIAN R HOLLAND PV MCCURDY PR
Citation: Mp. Busch et al., THE VIRAL ACTIVATION TRANSFUSION STUDY (VATS) - RATIONALE, OBJECTIVES, AND DESIGN OVERVIEW, Transfusion, 36(10), 1996, pp. 854-859
PROGNOSIS IN HIV-1 INFECTION PREDICTED BY THE QUANTITY OF VIRUS IN PLASMA
Authors: MELLORS JW RINALDO CR GUPTA P WHITE RM TODD JA KINGSLEY LA
Citation: Jw. Mellors et al., PROGNOSIS IN HIV-1 INFECTION PREDICTED BY THE QUANTITY OF VIRUS IN PLASMA, Science, 272(5265), 1996, pp. 1167-1170
GENETIC CORRELATES OF IN-VIVO VIRAL RESISTANCE TO INDINAVIR, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR
Authors: CONDRA JH HOLDER DJ SCHLEIF WA BLAHY OM DANOVICH RM GABRYELSKI LJ GRAHAM DJ LAIRD D QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M YANG T CHODAKEWITZ JA DEUTSCH PJ LEAVITT RY MASSARI FE MELLORS JW SQUIRES KE STEIGBIGEL RT TEPPLER H EMINI EA
Citation: Jh. Condra et al., GENETIC CORRELATES OF IN-VIVO VIRAL RESISTANCE TO INDINAVIR, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR, Journal of virology, 70(12), 1996, pp. 8270-8276
EFFECT OF STAVUDINE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRUS LOADAS MEASURED BY QUANTITATIVE MONONUCLEAR CELL-CULTURE, PLASMA RNA, ANDIMMUNE COMPLEX-DISSOCIATED ANTIGENEMIA
Authors: GRIFFITH BP BRETTSMITH H KIM G MELLORS JW CHACKO TM GARNER RB CHENG YC ALCABES P FRIEDLAND G
Citation: Bp. Griffith et al., EFFECT OF STAVUDINE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRUS LOADAS MEASURED BY QUANTITATIVE MONONUCLEAR CELL-CULTURE, PLASMA RNA, ANDIMMUNE COMPLEX-DISSOCIATED ANTIGENEMIA, The Journal of infectious diseases, 173(5), 1996, pp. 1252-1255
RECOMBINANT HUMAN GROWTH-HORMONE IN PATIENTS WITH HIV-ASSOCIATED WASTING - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Authors: SCHAMBELAN M MULLIGAN K GRUNFELD C DAAR ES LAMARCA A KOTLER DP WANG J BOZZETTE SA BREITMAYER JB HURLEY A JAVALY K PITT J PANG M HEALD AE SHIPP KW PEARCE D SOVA K PATE P BOSWELL SL FLYNN T POLSKY B HAVERSTICK L ROTHKOPF MM BLIFFEN DL ROSENFELD R PIERSON RN WINSON G TAI V BENNISON WM KENNEDY SM NEU TK ROBINSON CE SCHWALBERT RJ LAMARCA D KURITZKES DR RAY MG MELLORS JW BALSER BE BALSER JP
Citation: M. Schambelan et al., RECOMBINANT HUMAN GROWTH-HORMONE IN PATIENTS WITH HIV-ASSOCIATED WASTING - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 125(11), 1996, pp. 873
CORRELATION BETWEEN GENOTYPIC EVIDENCE OF HIV-1 RESISTANCE TO THE PROTEASE INHIBITOR MK-639 AND LOSS OF ANTIRETROVIRAL EFFECT IN TREATED PATIENTS
Authors: MELLORS JW MCMAHON DK CHODAKEWITZ JA SCHLEIF WA EMINI EA CONDRA JH
Citation: Jw. Mellors et al., CORRELATION BETWEEN GENOTYPIC EVIDENCE OF HIV-1 RESISTANCE TO THE PROTEASE INHIBITOR MK-639 AND LOSS OF ANTIRETROVIRAL EFFECT IN TREATED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 71-71
MUTATIONS IN HIV-1 REVERSE-TRANSCRIPTASE AND PROTEASE ASSOCIATED WITHDRUG-RESISTANCE
Authors: MELLORS JW LARDER BA SCHINAZI R DEVERSON C
Citation: Jw. Mellors et al., MUTATIONS IN HIV-1 REVERSE-TRANSCRIPTASE AND PROTEASE ASSOCIATED WITHDRUG-RESISTANCE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 92-92
USE OF STAVUDINE THERAPY FOR HIV-INFECTION
Authors: RIDDLER SA MELLORS JW
Citation: Sa. Riddler et Jw. Mellors, USE OF STAVUDINE THERAPY FOR HIV-INFECTION, Current opinion in infectious diseases, 8(6), 1995, pp. 483-488
ANTIRETROVIRAL ACTIVITY OF STAVUDINE (2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE, D4T)
Authors: RIDDLER SA ANDERSON RE MELLORS JW
Citation: Sa. Riddler et al., ANTIRETROVIRAL ACTIVITY OF STAVUDINE (2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE, D4T), Antiviral research, 27(3), 1995, pp. 189-203
Risultati: 1-25 | 26-31